Veracyte, J&J Launch NOBLE Trial For Lung Cancer Detection
Executive Summary
The 9,000-patient clinical study will identify genomic and other differences in lung cancer development and progression among patients with lung nodules detected by computed tomography.
You may also be interested in...
Optellum Joins J&J’s Lung Cancer Initiative
Optellum’s Virtual Nodule Clinic artificial intelligence technology will be part of Johnson & Johnson’s Lung Cancer Initiative, an ongoing research program intended to improve lung cancer survival rates through early intervention and prevention.
Veracyte Expands Into Urologic Cancer Testing By Acquiring Decipher For $600M
With the addition of Decipher, Veracyte now offers tests for seven of the 10 most common types of cancer in the US.
Johnson & Johnson Joins Forces With Veracyte For Lung Cancer Diagnostics
Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.